Lidocaïne Vaselinecrème Dmb

Lidocaine, the active ingredient in Lidocaïne Vaselinecrème Dmb, is a local anesthetic presented as a cream for rectal use. It provides topical analgesia for anorectal discomfort in adult patients. GNH USA supplies Lidocaïne Vaselinecrème Dmb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine cream is a topical local anesthetic used to relieve pain in the anorectal region.

Hemorrhoidal pain: reduces discomfort associated with internal and external hemorrhoids. Anal fissure pain: eases burning and stinging during bowel movements. Post‑procedural anorectal discomfort: alleviates pain after minor surgical or diagnostic procedures in the anal canal.

Lidocaine cream may cause local and systemic adverse reactions.

Common Side Effects: - Burning or stinging at the application site - Mild itching or erythema - Localized swelling or edema - Sensation of coldness or tingling - Dryness or flaking of the skin - Transient headache

Serious or Rare Side Effects: - Systemic toxicity (e.g., dizziness, seizures, cardiac arrhythmia) - Allergic reactions (e.g., rash, urticaria, angioedema) - Methemoglobinemia - Severe skin necrosis or ulceration - Persistent numbness beyond the intended area - Vision disturbances if absorbed in large amounts

Before using Lidocaïne Vaselinecrème Dmb, consider the following safety measures.

Allergy assessment: verify no known hypersensitivity to lidocaine or related amide anesthetics. Avoid broken skin: do not apply to ulcerated or severely inflamed mucosa. Limit application area: restrict use to the recommended surface area to prevent systemic absorption. Do not exceed recommended amount: follow prescriber instructions regarding quantity and frequency. Monitor for systemic signs: watch for dizziness, tinnitus, or cardiac symptoms. Store at room temperature: keep in the original container, protect from moisture and direct heat.

Lidocaine may interact with other medicines; awareness of these interactions helps maintain safety.

Major Interactions (Avoid): - Amiodarone: may increase lidocaine plasma levels, raising toxicity risk. - Class I anti‑arrhythmics (e.g., quinidine, procainamide): additive cardiac conduction effects. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can reduce lidocaine metabolism.

Moderate Interactions (Monitor Closely): - Beta‑blockers (e.g., propranolol): may enhance bradycardic effects. - Other local anesthetics: cumulative toxicity if used concurrently. - Anticonvulsants (e.g., phenytoin): may alter seizure threshold when lidocaine systemic levels rise.